Behavioral Activation Therapy for Subthreshold Depression in Stroke Patients: An Exploratory Randomized Controlled Trial
Qiuxue Sun,Hailian Xu,Wenyue Zhang,Yuqiu Zhou,Yumei Lv
DOI: https://doi.org/10.2147/NDT.S392403
IF: 2.989
2022-11-29
Neuropsychiatric Disease and Treatment
Abstract:Qiuxue Sun, 1, &ast Hailian Xu, 2, &ast Wenyue Zhang, 3 Yuqiu Zhou, 1 Yumei Lv 1 1 School of Nursing, Harbin Medical University (Daqing), Daqing, People's Republic of China; 2 School of Medical, Quzhou College of Technology, Quzhou, People's Republic of China; 3 Department of Rehabilitation, People's Hospital of Daqing, Daqing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yumei Lv, School of Nursing, Harbin Medical University (Daqing), No. 39 Xinyang Road, Longfeng District, Daqing, People's Republic of China, Email Background: Subthreshold depression (SD) is known to be a major risk factor for the development of post-stroke depression (PSD). Appropriate intervention to prevent the transition from SD to PSD is thus imperative. As a form of short-term psychotherapy adapted for individuals with cognitive and communication impairments, behavioral activation therapy (BAT) may be a suitable choice. However, the effects of BAT on psychological outcomes in stroke patients with SD has not been established. This study investigated the feasibility and effectiveness of BAT in reducing the development of depressive symptoms in this patient population. Methods: A double-blind, randomized controlled trial was performed. Seventy participants were randomized to either a BAT group (n=35) or a control group (n=35). Participants in the BAT group received a six-week BAT intervention. The feasibility of BAT was assessed by the number of sessions attended by participants, and the acceptability of BAT to participants and the incidence of adverse events were recorded. The primary clinical outcome measure was the Center for Epidemiological Studies Depression Scale (CES-D) and the 17-item Hamilton Depression Scale (HAMD-17) at baseline, six weeks, and three months after the group allocation. Secondary outcomes included behavioral activation and the incidence of depression. Results: The intervention was feasible and acceptable, with 94.3% of participants in the BAT group (33 of 35) attending at least five sessions. No adverse events were reported in either group. Compared with the control group, the BAT group showed significant improvements in the CES-D ( F =67.689, P < 0.05), HAMD-17 ( F =4.170, P < 0.05), and behavioral activation ( F =25.355, P < 0.05) scores after intervention, and these differences were maintained at the three-month assessment. Conclusion: BAT appears to be feasible and efficacious for reducing depressive symptoms and increasing behavioral activation among stroke patients with SD. The findings of this study may contribute to the primary prevention of PSD. Keywords: stroke, subthreshold depression, post-stroke depression, behavioral activation therapy Stroke is a common age-related disease that poses a significant threat to human health and is both the second leading cause of death and the main reason for disability. 1 Researchers revealed that the prevalence of stroke in China increased by 13.2% from 2013 to 2019, and the annual increase rate was 2.2%. 2 Stroke survivors may face a variety of complications like cognitive impairment and aphasia, or even affective disorder. While there are many emotional consequences of stroke, one of the most prevalent is depression. Post-stroke depression (PSD) can occur at every stage of the disease and is characterized by reduced motivation for rehabilitation and an increased incidence of adverse events. 3,4 PSD thus poses a challenge for the rehabilitation of stroke patients. While there is evidence for the effective treatment of PSD, there is an opportunity to prevent depression before it occurs. 5,6 Subthreshold depression(SD) is known to be a major risk factor for the development of PSD, it is well established that SD can also progress to PSD if not treated in time. 7,8 Identifying and treating SD from the outset could thus help reduce the future incidence of PSD and its accompanying adverse effects. SD is also relatively common, with estimates of 60% prevalence during the acute stroke episode and 38% in patients on discharge. 9 SD has been conceptualized in multiple ways, with some researchers referring to it as an intermediate stage between an absence of clinically relevant depressive symptoms and a full clinical disorder. 7,10 Studies have consistently reported that SD patients not only suffer from persistent depressive symptoms and reduced quality of life but also require more health services at greater economic cost. 8,11 Early interventions for SD that can reduce the risk of develop -Abstract Truncated-
psychiatry,clinical neurology